EZOFGA Trademark

Trademark Overview

On Thursday, October 19, 2023, a trademark application was filed for EZOFGA with the United States Patent and Trademark Office. The USPTO has given the EZOFGA trademark a serial number of 98231209. The federal status of this trademark filing is THIRD EXTENSION - GRANTED as of Wednesday, January 14, 2026. This trademark is owned by ViroPharma Biologics LLC. The EZOFGA trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical products, namely, budesonide oral suspension (BOS) for eosinophilic esophagitis (EoE)

General Information

Serial Number98231209
Word MarkEZOFGA
Filing DateThursday, October 19, 2023
Status732 - THIRD EXTENSION - GRANTED
Status DateWednesday, January 14, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 9, 2024

Trademark Statements

Goods and Servicespharmaceutical products, namely, budesonide oral suspension (BOS) for eosinophilic esophagitis (EoE)

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, October 25, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameViroPharma Biologics LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressLexington, MA 02421
Party NameViroPharma Biologics LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressLexington, MA 02421

Trademark Events

Event DateEvent Description
Monday, October 23, 2023NEW APPLICATION ENTERED
Wednesday, October 25, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, June 4, 2024ASSIGNED TO EXAMINER
Wednesday, June 5, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, June 19, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 9, 2024PUBLISHED FOR OPPOSITION
Tuesday, July 9, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 3, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, November 6, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, November 6, 2024SOU EXTENSION 1 FILED
Wednesday, November 6, 2024SOU EXTENSION 1 GRANTED
Wednesday, November 6, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, June 18, 2025SOU TEAS EXTENSION RECEIVED
Wednesday, June 18, 2025SOU EXTENSION 2 FILED
Wednesday, June 18, 2025SOU EXTENSION 2 GRANTED
Thursday, June 19, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, January 12, 2026TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, January 12, 2026ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, January 12, 2026TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, January 14, 2026SOU TEAS EXTENSION RECEIVED
Wednesday, January 14, 2026SOU EXTENSION 3 FILED
Wednesday, January 14, 2026SOU EXTENSION 3 GRANTED
Thursday, January 15, 2026NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Related Keywords

ezofga suspension eosinophilic esophagitis oral budesonide products namely pharmaceutical